UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Apr. 30, 2021	Apr. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net (Loss) Income	$ (26,910,363)	$ (22,353,394)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	783,173	609,007
Amortization of operating lease right-of-use assets	57,514	71,987
Stock compensation expense	2,160,788	1,630,111
Shares issued for services	10,993	293,600
Loss of disposal of fixed assets	7,324	189,366
Amortization of debt discount	975,835	3,795,606
Gain on settlement of accrued interest	(370,553)	0
Gain on forgiveness of PPP loan	(73,100)	0
Change in fair value of derivative liabilities - convertible notes	(432,653)	(642,221)
Change in fair value of derivative liabilities - warrants	(3,718,735)	(9,913)
Change in fair value of derivative liabilities - downside protection	0	4,764,341
Bad debt expense	0	10,981
Increase in notes payable due to default	255,080	94,214
Change in fair value of common stock payable	(102,382)	(18,871)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	112,568	16,599
Inventory	510,141	(281,905)
Accounts payable and accrued expenses	17,476,534	6,057,005
Interest payable to foundation	749,493	626,867
Contract liabilities	7,000,000	0
Operating lease liabilities	(56,173)	(70,685)
Other current assets	(174,513)	(286,096)
Other assets	0	11,383
Net cash used in operating activities	(1,739,029)	(5,492,018)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	0	(4,616)
Cash received in acquisition of a business, net of cash paid	0	49,305
Net cash provided by investing activities	0	44,689
CASH FLOWS FROM FINANCING ACTIVITIES
Loan (repayments to) and proceeds from related party	(15,000)	10,000
Payment of notes payable	(2,349,996)	(935,731)
Proceeds from note payable	2,050,200	6,381,448
Proceeds from issuance of common stock	1,854,257	109,770
Issuance of common stock in a private placement (PIPE), net of fees	1,850,000	0
Proceeds from exercise of warrants	9,143	0
Net cash provided by financing activities	3,398,604	5,565,487
Net increase in cash and cash equivalents	1,659,575	118,158
Cash and cash equivalents, beginning of period	15,452	298,485
Cash and cash equivalents, end of period	1,675,027	416,643
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	50,000	25,000
Supplemental Disclosure of Non-Cash Investing and Financing Activities
Reduction of derivative liabilities	575,987	3,041,502
Issuance of shares--common stock payable	1,472,826	936,395
Issuance of common stock for conversion of debt	1,618,604	4,489,910
Subscription receivable	0	765,970
Shares issued as debt issuance cost	178,831	151,230
Warrants granted with notes payable	740,028
Discount on derivative liability upon issuance of debt	0	1,834,607
Settlement of subsidiary's debt with issuance of stock	0	32,212
Issuance of common stock and warrants from PIPE offering	21,574,216	0
Elimination of derivative liability from exercise of warrants	$ 1,840,530	$ 0